594 related articles for article (PubMed ID: 32942005)
1. Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined With Radiation.
Dyer BA; Feng CH; Eskander R; Sharabi AB; Mell LK; McHale M; Mayadev JS
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):396-412. PubMed ID: 32942005
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Lee L; Matulonis U
Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer.
Feng CH; Mell LK; Sharabi AB; McHale M; Mayadev JS
Semin Radiat Oncol; 2020 Oct; 30(4):273-280. PubMed ID: 32828383
[TBL] [Abstract][Full Text] [Related]
4. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
[TBL] [Abstract][Full Text] [Related]
5. Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer.
Dyer BA; Zamarin D; Eskandar RN; Mayadev JM
J Natl Compr Canc Netw; 2019 Jan; 17(1):91-97. PubMed ID: 30659133
[TBL] [Abstract][Full Text] [Related]
6. Optimizing immunotherapy for gynecologic cancers.
Rubinstein MM; Makker V
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):1-8. PubMed ID: 31833942
[TBL] [Abstract][Full Text] [Related]
7. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
Hu ZI; Ho AY; McArthur HL
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
[TBL] [Abstract][Full Text] [Related]
8. PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.
Tuyaerts S; Van Nuffel AMT; Naert E; Van Dam PA; Vuylsteke P; De Caluwé A; Aspeslagh S; Dirix P; Lippens L; De Jaeghere E; Amant F; Vandecasteele K; Denys H
BMC Cancer; 2019 May; 19(1):506. PubMed ID: 31138229
[TBL] [Abstract][Full Text] [Related]
9. Combination radiation and immunotherapy in gynecologic malignancies-a comprehensive review.
Ladbury C; Germino E; Novak J; Liu J; Horne Z; Dyer B; Glaser S
Transl Cancer Res; 2021 May; 10(5):2609-2619. PubMed ID: 35116574
[TBL] [Abstract][Full Text] [Related]
10. Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center.
Sharabi A; Kim SS; Kato S; Sanders PD; Patel SP; Sanghvi P; Weihe E; Kurzrock R
Oncologist; 2017 Jun; 22(6):631-637. PubMed ID: 28550027
[TBL] [Abstract][Full Text] [Related]
11. Combined modality including novel sensitizers in gynecological cancers.
Zhou Y; Espenel S; Achkar S; Leary A; Gouy S; Chargari C
Int J Gynecol Cancer; 2022 Mar; 32(3):389-401. PubMed ID: 35256428
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy: an evolving paradigm in the treatment of advanced cervical cancer.
Eskander RN; Tewari KS
Clin Ther; 2015 Jan; 37(1):20-38. PubMed ID: 25592089
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.
Santin AD; Bellone S; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Curr Pharm Des; 2005; 11(27):3485-500. PubMed ID: 16248803
[TBL] [Abstract][Full Text] [Related]
14. Advances in immunotherapy in cervical cancer.
Grau JF; Farinas-Madrid L; Garcia-Duran C; Garcia-Illescas D; Oaknin A
Int J Gynecol Cancer; 2023 Mar; 33(3):403-413. PubMed ID: 36878562
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in Gynecologic Cancers: Are We There Yet?
Pakish JB; Jazaeri AA
Curr Treat Options Oncol; 2017 Aug; 18(10):59. PubMed ID: 28840453
[TBL] [Abstract][Full Text] [Related]
16. Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer.
Li Y; Shen F; Tan Q; Chen Y; Gu Y
Technol Cancer Res Treat; 2023; 22():15330338231208846. PubMed ID: 37908109
[TBL] [Abstract][Full Text] [Related]
17. Advances in immunotherapy for cervical cancer.
Wendel Naumann R; Leath CA
Curr Opin Oncol; 2020 Sep; 32(5):481-487. PubMed ID: 32740092
[TBL] [Abstract][Full Text] [Related]
18. Major clinical research advances in gynecologic cancer in 2015.
Suh DH; Kim M; Kim HJ; Lee KH; Kim JW
J Gynecol Oncol; 2016 Nov; 27(6):e53. PubMed ID: 27775259
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in Cervical Cancer.
Mauricio D; Zeybek B; Tymon-Rosario J; Harold J; Santin AD
Curr Oncol Rep; 2021 Apr; 23(6):61. PubMed ID: 33852056
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in cervix cancer.
Attademo L; Tuninetti V; Pisano C; Cecere SC; Di Napoli M; Tambaro R; Valabrega G; Musacchio L; Setola SV; Piccirillo P; Califano D; Spina A; Losito S; Greggi S; Pignata S
Cancer Treat Rev; 2020 Nov; 90():102088. PubMed ID: 32827839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
